ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| US BANCORP \DE\ | 1,083 | $1,061 | 0.00% |
| RHUMBLINE ADVISERS | 3,784 | $3,708 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 104,505 | $102,415 | 0.00% |
| STIFEL FINANCIAL CORP | 48,328 | $47,361 | 0.00% |
| Russell Investments Group, Ltd. | 86,334 | $84,606 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,255 | $3,190 | 0.00% |
| NORTHERN TRUST CORP | 228,710 | $224,135 | 0.00% |
| UBS Group AG | 31,160 | $30,537 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SouthState Corp | 314 | $308 | 0.00% |
| Qube Research & Technologies Ltd | 31,562 | $30,931 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 970,238 | $951,083 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 21,714 | $21,280 | 0.00% |
| JANE STREET GROUP, LLC | 268,484 | $263,114 | 0.00% |
| STATE STREET CORP | 302,449 | $296,400 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 200,000 | $196,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 11,640 | $11,407 | 0.00% |
| Private Advisor Group, LLC | 28,606 | $28,034 | 0.00% |
| VANGUARD GROUP INC | 4,741,362 | $4,646,535 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 200 | $196 | 0.00% |
External links
This page lists ESPERION THERAPEUTICS INC NE's shareholders in Q3 2023. To view ESPERION THERAPEUTICS INC NE's shareholder history, click here.